Transcriptional Inflammatory Signature in Healthy Donors and Different Radiotherapy Cancer Patients

Area of Science:

• Oncology
• Radiation Oncology
• Molecular Biology

Background:

• Cancer and ionizing radiation exposure are linked to inflammation.
• Identifying radiation-specific gene expression changes is crucial for understanding treatment effects.

Purpose of the Study:

• To discover a set of radiation-specific inflammation-associated gene signatures in the blood of radiotherapy patients.
• To establish a foundation for developing biomarkers for radiation exposure, sensitivity, and toxicity.

Main Methods:

• Differential gene expression analysis of 249 inflammatory genes in blood samples from 63 cancer patients undergoing radiotherapy and healthy donors.
• Analysis included samples taken before, during, and after radiotherapy treatment.
• Validation of identified genes using quantitative reverse transcription polymerase chain reaction (MQRT-PCR).

Main Results:

• A distinct signature of 31 inflammation-associated genes (15 up-regulated, 16 down-regulated) was identified in radiotherapy patients.
• This radiation signature was consistent across different cancer types and independent of patient immune status.
• No significant inflammatory expression differences were found between healthy donors and cancer patients before radiotherapy.

Conclusions:

• A 31-gene signature in blood can identify radiation exposure in cancer patients undergoing radiotherapy.
• This signature holds potential for developing personalized radiotherapy strategies by predicting radiation sensitivity and toxicity.
• Further research can build upon these findings for improved patient management.